RvE1 uses the LTB4 receptor BLT1 to increase [Ca2+]i and stimulate mucin secretion in cultured rat and human conjunctival goblet cells.

[1]  K. Tracey,et al.  HMGB1–C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis , 2019, Proceedings of the National Academy of Sciences.

[2]  A. Murakami,et al.  Dietary ω-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th2 immune responses , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  C. Serhan,et al.  Resolvin D1 Treatment on Goblet Cell Mucin and Immune Responses in the Chronic Allergic Eye Disease (AED) Model , 2018, Mucosal Immunology.

[4]  C. Serhan,et al.  Signaling pathways activated by resolvin E1 to stimulate mucin secretion and increase intracellular Ca2+ in cultured rat conjunctival goblet cells , 2018, Experimental eye research.

[5]  T. Yokomizo,et al.  Identification, signaling, and functions of LTB4 receptors. , 2017, Seminars in immunology.

[6]  C. Serhan,et al.  Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways , 2017, Investigative ophthalmology & visual science.

[7]  C. Serhan,et al.  Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics. , 2017, Prostaglandins, leukotrienes, and essential fatty acids.

[8]  Jeffrey A. Bair,et al.  Lipoxin A4 activates ALX/FPR2 Receptor to Regulate Conjunctival Goblet Cell Secretion , 2016, Mucosal Immunology.

[9]  C. Serhan,et al.  Lipoxin A4 Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells , 2016, Scientific Reports.

[10]  I. Gipson Goblet cells of the conjunctiva: A review of recent findings , 2016, Progress in Retinal and Eye Research.

[11]  L. Contreras-Ruiz,et al.  Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090. , 2016, Experimental eye research.

[12]  H. Inoue,et al.  A turn on and a turn off: BLT1 and BLT2 mechanisms in the lung , 2014, Expert review of respiratory medicine.

[13]  R. Hodges,et al.  Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins. , 2013, Experimental eye research.

[14]  C. Serhan,et al.  Resolution phase lipid mediators of inflammation: agonists of resolution. , 2013, Current opinion in pharmacology.

[15]  Z. Pelikan Inflammatory mediator profiles in tears accompanying keratoconjunctival responses induced by nasal allergy , 2013, British Journal of Ophthalmology.

[16]  C. Serhan,et al.  Resolvin D1 and Aspirin-Triggered Resolvin D1 Regulate Histamine-stimulated Conjunctival Goblet Cell Secretion , 2013, Mucosal Immunology.

[17]  C. Schwartz,et al.  Resolvin E1 (RX-10001) Reduces Corneal Epithelial Barrier Disruption and Protects Against Goblet Cell Loss in a Murine Model of Dry Eye , 2012, Cornea.

[18]  Dayu Li,et al.  Effect of histamine on Ca(2+)-dependent signaling pathways in rat conjunctival goblet cells. , 2012, Investigative ophthalmology & visual science.

[19]  C. Serhan,et al.  Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators. , 2011, Biochimica et biophysica acta.

[20]  C. Serhan,et al.  Impaired Phagocytosis in Localized Aggressive Periodontitis: Rescue by Resolvin E1 , 2011, PloS one.

[21]  C. Serhan,et al.  Conjunctival Goblet Cell Secretion Stimulated by Leukotrienes Is Reduced by Resolvins D1 and E1 To Promote Resolution of Inflammation , 2011, The Journal of Immunology.

[22]  C. Serhan,et al.  Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. , 2011, The Journal of clinical investigation.

[23]  Y. Figenschau,et al.  Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin21-157 , 2010, Arthritis research & therapy.

[24]  Charles N. Serhan,et al.  Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation1 , 2007, The Journal of Immunology.

[25]  I. Gipson,et al.  Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. , 2003, Investigative ophthalmology & visual science.

[26]  S. Marullo,et al.  Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor , 2002, Nature Medicine.

[27]  Takao Shimizu,et al.  A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. , 2000, The Journal of experimental medicine.

[28]  J. Stankova,et al.  Signalling through the leukotriene B4 receptor involves both alphai and alpha16, but not alphaq or alpha11 G-protein subunits. , 1998, The Biochemical journal.

[29]  D. Griswold,et al.  Conjunctival leukocyte infiltration evoked by leukotrienes: differing responses among rodent species. , 1994, Journal of lipid mediators and cell signalling.

[30]  K. Krause,et al.  Leukotriene B4 stimulation of phagocytes results in the formation of inositol 1,4,5-trisphosphate. A second messenger for Ca2+ mobilization. , 1986, The Biochemical journal.